Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

Prophylactic donor lymphocyte infusion (pDLI) could reduce relapse in patients with refractory/relapsed acute leukemia (RRAL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but optimal timing of pDLI remains uncertain. We compared the outcomes of two strategies for pDLI b...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiongqiong, Fan, Zhiping, Huang, Fen, Xu, Na, Nie, Danian, Lin, Dongjun, Guo, Ziwen, Shi, Pengcheng, Wang, Zhixiang, Jiang, Ling, Sun, Jing, Jiang, Zujun, Liu, Qifa, Xuan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966710/
https://www.ncbi.nlm.nih.gov/pubmed/33747904
http://dx.doi.org/10.3389/fonc.2021.554503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966710/
https://www.ncbi.nlm.nih.gov/pubmed/33747904
http://dx.doi.org/10.3389/fonc.2021.554503

Ejemplares similares